What is the most promising treatment for Alzheimer's in 2023?
The U.s food and drug administration has granted approval for a new Alzheimer's drug, Leqembi (lecanemab-irmb) . The new treatment for Alzheimer has been granted through the accelerated approval pathway. Leqembi is an Alzheimer's drug breakthrough. It is the second medication in a new category that targets the underlying pathophysiology of Alzheimer's disease. This advancement is a crucial step forward in the ongoing battle to effectively treat this challenging condition.
Are you curious about the latest advancements in Alzheimer’s treatment drug? Read on!
Your health is too important to ignore – schedule your appointment now.
Are there any new drugs or medications for Alzheimer's in 2023?
As of now, in 2023 Leqembi is the only new medicine for Alzheimer’s disease. In July 2023, the US Food and Drug Administration (FDA) granted full approval for Lecanemab as a new Alzheimer’s drug. This allows healthcare professionals to administer the drug to patients with early Alzheimer's in the USA under the name Leqembi.
Remternetug is a new drug made by Eli Lilly for early-stage Alzheimer's. It's immunotherapy like Donanemab but with potential improvements. Unlike other immunotherapies, it's given through skin injections. It aims for better effectiveness and fewer side effects. This method is similar to insulin pens used for diabetes.
Can lifestyle changes slow down Alzheimer's progression? Find out now!
Can lifestyle changes or interventions help slow down Alzheimer's progression in 2023?
Some studies suggest that our diet can impact our brain's ability to think and remember as we age. The Mediterranean diet and the related MIND diet have shown cognitive benefits in studies. The diet includes elements to lower blood pressure.
Researchers are actively studying these diets to determine if they can prevent or delay Alzheimer's disease. The Mediterranean diet focuses on fruits, vegetables, whole grains, fish, and healthy fats. These elements have shown promising evidence in supporting brain health.
One study, based on older adults, revealed that eating leafy green vegetables daily may slow down age-related cognitive decline. It was also found that eating fish regularly is associated with high cognitive function. It also reduces the rate of cognitive decline with age.
Hence studies are still going on to establish the facts that lifestyle changes can actually impact Alzeigmer’s progression.
Take charge of your health and your life. Contact us today!
Unveiling the potential side effects of new Alzheimer's treatments. Find out below!
What are the potential side effects of new Alzheimer's treatments?
Like any medicine, Leqembi may have side effects. The most common ones are brain swelling and bleeding, which usually improve with time. Some people may experience headaches, confusion, dizziness, vision changes, nausea, and seizures. It happens as a result of swelling and bleeding. Other side effects include nausea, vomiting, and changes in blood pressure.
How effective are the new treatments for Alzheimer's compared to existing ones?
Before Leqembi’s approval, the full results from a final clinical trial called Clarity-AD were released. The trials indicated that the new Alzheimer’s drug was able to remove the amyloid and tau proteins from people’s brains who have early Alzheimer’s.
Leqembi slowed the decline in thinking and memory skills by 27%. It improved their quality of life by up to 56%.
Your well-being is our priority - call us to book your appointment today
Get the scoop on the clinical trials for new Alzheimer's treatments in 2023!
Are there any clinical trials for new Alzheimer's treatments in 2023?
Yes, the approval of the new Alzheimer’s drug is based upon the results from the clinical study Clarity AD. The study was conducted on 856 patients who had early-stage Alzheimer’s disease. Before the study, it was made sure that the patients had the presence of harmful amyloid protein. This protein is known to potentially cause dementia.
Phase 3 of the clinical trial study showed results that proved that the new Alzheimer’s drug has effective benefits. The data reported from phase 3 of this study led to the accelerated approval of Leqembi.
What are the latest advancements in Alzheimer's treatment?
Leqembi is a new Alzheimer’s drug. It is meant to be given to patients who have mild Alzheimer’s. As compared to earlier medications Leqembi proved to be more effective in removing amyloid proteins. Hence, getting the accelerated approval.
